Toronto, ON (PRWEB) March 01, 2022 Technology-enabled decentralized clinical trials (DCTs) involve the use of wearable biosensors and other digital tools
/PRNewswire/ EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, and THREAD™, a leading technology and.
/PRNewswire/ EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, and THREAD™, a leading technology and.
/PRNewswire/ THREAD, a leading technology and service provider enabling decentralized clinical trials (DCTs), today announced that it has acquired Modus.